| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $75.7M | +10.1% |
| Cost of Revenue | $30.8M | -4.1% |
| R&D Expense | $134.9M | +4.7% |
| SG&A Expense | $113.7M | +30.9% |
| Operating Income | -$203.6M | -8.0% |
| Interest Expense | $12.5M | -18.5% |
| Pre-tax Income | -$213.5M | -29.9% |
| Income Tax | $449K | -5.1% |
| Net Income | -$86.6M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $178.3M | -41.7% |
| Accounts Receivable | $28.2M | +22.0% |
| Inventory | $14.2M | +43.6% |
| Current Assets | $230.4M | -33.5% |
| Total Assets | $294.3M | -25.8% |
| Current Liabilities | $127.7M | +26.4% |
| Long-term Debt | $91.7M | +113.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$179.4M | -53.9% |
| Capital Expenditures | $2.7M | -40.5% |
| Investing Cash Flow | -$22.9M | -156.6% |
| Financing Cash Flow | $75.3M | -49.4% |
| Free Cash Flow | -$182.1M | -50.4% |
| -33.8% |
| EPS (Basic) | -$0.97 | -22.8% |
| EPS (Diluted) | -$0.97 | -22.8% |
| Total Liabilities |
| $244.3M |
| +43.2% |
| Stockholders' Equity | $41.7M | -61.6% |